Navigation Links
Direct Drive Rotary Tables with Large Apertures from IntelLiDrives
Date:1/8/2013

Philadelhia, PA (PRWEB) January 08, 2013

IntelLiDrives, Inc. released direct drive rotary tables AccuRing Series features superior angular positioning and velocity control with exceptionally large apertures.

AccuRing Series rotary table offer an advantage of the large aperture rotary stages with zero backlash and no gear wear or gear vibration. They are significantly faster than worm and gear drives and maintain system accuracy and repeatability over time, providing higher equipment productivity with better accuracy of the processed parts. Higher accuracy and no backlash allow customers to produce more accurate and consistent products.

AccuRing direct drive rotary stages provide 200 rpm continuous rotation when compared to only 10 rpm transmission based rotary tables with similar apertures and payload capacity.

Angular contact bearings, used in AccuRings, maximize performance with respect to wobble, moment stiffness, and rotating friction. A precision-machined rotating shaft further minimizes wobble.

To further maximize the positioning performance, AccuRing Series direct-drive rotary stages utilize brushless modular RotoLinear motor technology. These motors have all of the advantages of a brushless direct drive motor – no brushes to wear, no gear trains to maintain, and high acceleration and high speeds. These features make AccuRings ideal for the applications requiring contoured motion, smooth scan velocity and precise incremental steps.

Accurate positioning performance of AccuRings is assured with encoder resolutions up to 0.16 arc sec. The motor and ring encoder are directly coupled to a rotating shaft. The absence of gear trains and mechanical couplings eliminates position errors caused by hysteresis, windup or backlash. As a result, accuracy of ±10 arc-sec and bi-directional repeatability of ±1 arc-sec are attainable.

Applications for the AccuRings include single and multi-axis laser testing, antenna testing, inertial navigation device testing, photonic component alignment, high-accuracy laser machining and precision wafer inspection. These rotary stages can also be configured as multi-axis gimbals.

IntelLiDrives, Inc. also offers a wide range of servo amplifiers and advanced controllers to provide a complete, integrated package.

Main features of the AccuRing Rotary tables Series:

•low profile
•high resolution
•precision bearings
•large center aperture
•direct drive brushless motor
•can be mounted in any orientation

AccuRing Rotary Tables Specifications:

•torque up to 1,000 Nm
•resolution to 1 arc-sec
•speed 200 rpm
•accuracy 10 arc-sec
•table height 100 mm
•clear aperture 250 to 500 mm

For additional information contact:
IntelLiDrives, Inc.
8510 Bustleton Ave
Philadelphia, PA 19152
tel: (215) 728-6804
fax: (215) 745-9459

e-mail: admin(at)intellidrives(dot)com
web: http://www.intellidrives.com

Read the full story at http://www.prweb.com/releases/rotary_table/rotary_tables/prweb10267353.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Direct Marketing Partners Wins Sales Lead Management’s “Most Influential” in 2012
2. HealthEconomics.Com Appoints New Director of Information Technology and Operations
3. Bar Harbor BioTechnology to Offer Direct Sales Starting in 2013; Development of StellARrays™ for C.elegans and Zebrafish Underway
4. IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology
5. Cell Therapeutics, Inc.s (CTI) Board of Directors Approves Amendment of Shareholder Rights Plan
6. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
7. Lakewood-Amedex Inc. Appoints Marie E. Knight To Its Board Of Directors
8. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
9. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
10. Appeal Courts Direction on Claim Construction Is Strategically Important for Butamaxs Case Against Gevo Scheduled for April 2013
11. Egenix, Inc. Announces New Director, John Reid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... YORK , Feb. 20, 2017 This report ... by the following Product Types: Xylanase, Amylase, Cellulase, and Others. ... Canada , Japan , ... Latin America , and Rest of World. ... Annual estimates and forecasts are provided for the period ...
(Date:2/20/2017)... ... February 20, 2017 , ... PuraCath Medical, ... with peritoneal dialysis, announced today that it has published the result of its ... Peritoneal Dialysis International (PDI), the official Journal of the International Society for ...
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf ... Poster legt metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... ... Yoav Peretz , Scientific Director bei ImmuneCarta, einen ... zum Nachweis intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen ...
(Date:2/17/2017)... , Feb. 17, 2017  BioGenex, a ... announce development of a novel system for quantitative ... with the University of Rochester (NY, USA) and ... The new system is able to accurately quantify ... HER2 (Human epidermal growth factor receptor-2) in clinical ...
Breaking Biology Technology:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/7/2017)... WARSAW, Ind. , Feb. 7, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Lotte New York Palace Hotel on Wednesday, February 15, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):